ClinicalTrials.Veeva

Menu

Application of Deuterated Water (D2O) to Define the Etiology of Musculoskeletal Decline in Ageing and the Efficacy of Nutritional Supplementation

U

University of Nottingham

Status

Unknown

Conditions

Healthy

Treatments

Behavioral: Exercise

Study type

Interventional

Funder types

Other

Identifiers

NCT02505438
DMTD2O13

Details and patient eligibility

About

Maintaining muscle mass and function is important in healthy ageing to maintain quality of life. Loss of muscle mass is major problem, as beyond the age ~50, muscle mass declines by ~1-2% a year. To prevent this loss, the investigators need to understand the mechanism regulating muscle mass as we age. In this project the investigators aim to determine these mechanisms using a new technique of heavy water ingestion, this allows measurement of multiple aspects of skeletal muscle mass metabolism e.g. protein synthesis, over long periods (6 weeks) as people go about their normal everyday activities. The investigators also aim to determine the influence of resistance exercise training on older muscle, as well as differences between men and women in muscle responses to exercise and nutrition HMB (beta-hydroxy-beta-methylbutyrate).

Enrollment

48 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Young (18-30y) and old (60-75y) individuals who are generally healthy and recreationally active

Exclusion criteria

  • Active cardiovascular disease
  • Cerebrovascular disease including previous stroke, aneurysm (large vessel or intracranial)
  • Respiratory disease including pulmonary hypertension or Chronic obstructive pulmonary disease, Hyper/ hypo parathyroidism, hyper/ hypothyroidism,
  • Cushing's disease, diabetes
  • Active inflammatory bowel disease
  • Renal disease
  • Malignancy
  • Recent steroid treatment (within 6 mo), or hormone replacement therapy Clotting dysfunction
  • Musculoskeletal or neurological disorders
  • Any disease requiring long-term drug prescriptions, including statins

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

48 participants in 4 patient groups

Young Unilateral Exercise
Experimental group
Description:
Young Individuals (18-30y) studied before and after 6 weeks unilateral resistance exercise training
Treatment:
Behavioral: Exercise
Old Unilateral Exercise
Experimental group
Description:
Old individuals (65-75y) studied before and after 6 weeks of unilateral resistance exercise training
Treatment:
Behavioral: Exercise
Old Unilateral Exercise and HMB
Experimental group
Description:
Old individuals (65-75y) studied before and after 6 weeks of unilateral resistance exercise training with HMB (beta-hydroxy-beta-methylbutyrate) supplementation
Treatment:
Behavioral: Exercise
Old Unilateral Exercise and Omega 3
Experimental group
Description:
Old individuals (65-75y) studied before and after 6 weeks of unilateral resistance exercise training with Omega 3 supplementation
Treatment:
Behavioral: Exercise

Trial contacts and locations

1

Loading...

Central trial contact

Ken Smith, PhD; Matthew Brook

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems